Regulatory T cells in the pathogenesis of type 2 diabetes mellitus retinopathy by miR-155

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 11, 2015, Pages 2010-2015

  Yang, T T ^a   Song, S J ^a   Xue, H B ^a   Shi, D F ^a   Liu, C M ^a   Liu, H ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; miR 155; Regulatory T cells; Type 2 diabetes mellitus

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MICRORNA 155; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; MICRORNA; MIRN155 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CD25+ T LYMPHOCYTE; CD4 T CELL COUNT TEST; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROLIFERATIVE DIABETIC RETINOPATHY; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; COMPLICATION; DIABETIC RETINOPATHY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE COUNT; MALE; MICRORNAS; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84942238471     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. HAO YM, LIU QJ, WANG RY, CAO YP, ZHANG Y, ZUO LF. Single nucleotide polymorphisms on SHIP2 is associated with Type 2 diabetes mellitus in Chinese Han population. Eur Rev Med Pharmacol Sci 2015; 19: 129-137.
2. MEO SA, MEMON AN, SHEIKH SA, ROUQ FA, USMANI AM, HASSAN A, ARIAN SA. Effect of environmental air pollution on type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci 2015; 19: 123-128.
3. ZHAO L, HU FX. ?-Lipoic acid treatment of aged type 2 diabetes mellitus complicated with acute cerebral infarction. Eur Rev Med Pharmacol Sci 2014; 18: 3715-3719.
4. DOGAN M, OZSOY E, DOGANAY S, BURULDAY V, FIRAT PG, OZER A, ALKAN A. Brain diffusion-weighted imaging in diabetic patients with retinopathy. Eur Rev Med Pharmacol Sci 2012 Jan; 16: 126-131.
5. GIUSTI C, GARGIULO P. Advances in biochemical mechanisms of diabetic retinopathy. Eur Rev Med Pharmacol Sci 2007; 11: 155-163.
6. GIUSTI C. Novel diagnostic and therapeutic approaches to the diabetic retinopathy. Eur Rev Med Pharmacol Sci 2001; 5: 155-166.
7. MARCHAND V, BRANLANT C. Quantification and quality control of a small non-coding RNA preparation. Methods Mol Biol 2015; 1296: 17-28.
8. CLERGET G, ABEL Y, REDERSTORFF M. Small Non-Coding RNAs: A Quick Look in the Rearview Mirror. Methods Mol Biol 2015; 1296: 3-9.
9. MCCLELLAND AD, KANTHARIDIS P. microRNA in the development of diabetic complications. Clin Sci (Lond) 2014; 126: 95-110.
10. NAVARRO F, LIEBERMAN J. Small RNAs guide hematopoietic cell differentiation and function. J Immunol 2010; 184: 5939-5947.
11. SHEN BL, QU QS, MIAO SZ, LIU BL, LIU RY, GU DF. Study on the effects of regulatory T cells on renal function of IgAN rat model. Eur Rev Med Pharmacol Sci 2015; 19: 284-288.
12. PAGGI A, AMOROSO A, FERRI GM, MARIOTTI A, PELLEGRINO C, AFELTRA A. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets. Eur Rev Med Pharmacol Sci 1998; 2: 11-19.
13. O'CONNELL RM, RAO DS, CHAUDHURI AA, BALTIMORE D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111-122.
14. SCANLON PH, ALDINGTON SJ, STRATTON IM. Epidemiological issues in diabetic retinopathy. Middle East Afr J Ophthalmol 2013; 20: 293-300.
15. YAU JW, ROGERS SL, KAWASAKI R, LAMOUREUX EL, KOWALSKI JW, BEK T, CHEN SJ, DEKKER JM, FLETCHER A, GRAUSLUND J, HAFFNER S, HAMMAN RF, IKRAM MK, KAYAMA T, KLEIN BE, KLEIN R, KRISHNAIAH S, MAYURASAKORN K, O'HARE JP, ORCHARD TJ, PORTA M, REMA M, ROY MS, SHARMA T, SHAW J, TAYLOR H, TIELSCH JM, VARMA R, WANG JJ, WANG N, WEST S, XU L, YASUDA M, ZHANG X, MITCHELL P, WONG TY; METAANALYSIS FOR EYE DISEASE (META-EYE) STUDY GROUP. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35: 556-564.
16. HENG LZ, COMYN O, PETO T, TADROS C, NG E, SIVAPRASAD S, HYKIN PG. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med 2013; 30: 640-650.
17. CHENG SF, LI L, WANG LM. miR-155 and miR-146b negatively regulates IL6 in Helicobacter pylori (cagA+) infected gastroduodenal ulcer. Eur Rev Med Pharmacol Sci 2015; 19: 607-613.
18. BAO JL, LIN L. MiR-155 and miR-148a reduce cardiac injury by inhibiting NF-?B pathway during acute viral myocarditis. Eur Rev Med Pharmacol Sci 2014; 18: 2349-2356.
19. SAKAGUCHI S, YAMAGUCHI T, NOMURA T, ONO M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787.
20. QIN FX. Dynamic behavior and function of Foxp3 regulatory T cells in tumor bearing host. Cell Mol Immunol 2009; 6: 3-13.
21. HUEHN J, POLANSKY JK, HAMANN A. Epigenetic control of Foxp3 expression: the key to a stable regulatory T cell lineage? Nat Rev Immunol 2009; 9: 83-89.
22. YAO R, MA YL, LIANG W, LI HH, MA ZJ, YU X, LIAO YH. MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One 2012; 7: e46082.
23. ZHOU Q, HAUPT S, KREUZER JT, HAMMITZSCH A, PROFT F, NEUMANN C, LEIPE J, WITT M, SCHULZE-KOOPS H, SKAPENKO A. Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis. Ann Rheum Dis 2014; 74: 1265-1274.
24. LIND EF, ELFORD AR, OHASHI PS. Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. J Immunol 2013; 190: 1210-1216.
25. ELTON TS, SELEMON H, ELTON SM, PARINANDI NL. Regulation of the MIR155 host gene in physiological and pathological processes. Gene 2013; 532: 1-12.
26. MICHAEL H, LI Y, WANG Y, XUE D, SHAN J, MAZER BD, MCCUSKER CT. TGF-?-mediated airway tolerance to allergens induced by peptide-based immunomodulatory mucosal vaccination. Mucosal Immunol 2015 Mar 18. Epub ahead of print.
27. CHEN W, KONKEL JE. Development of thymic Foxp3(+) regulatory T cells: TGF-matters. Eur J Immunol 2015; 45: 958-965.
28. TAMAKA K, SEIKE M, HAGIWARA T, SATO A, OHTSU H. Histamine suppresses regulatory T cells medi ated by TGF-in murine chronic allergic contact dermatitis. Exp Dermatol 2015; 24: 280-284.
29. LIU Y, ZHENG WK, GAO WS, SHEN Y, DING WY. Function of TGF-beta and p38 MAKP signaling pathway in osteoblast differentiation from rat adiposederived stem cells. Eur Rev Med Pharmacol Sci 2013; 17: 1611-1619.
30. WANG XG, MENG Q, QI FM, YANG QF. Blocking TGF-inhibits breast cancer cell invasiveness via ERK/S100A4 signal. Eur Rev Med Pharmacol Sci 2014; 18: 3844-3853.